Citi analyst Veronika Dubajova resumed coverage of Fresenius Medical with a Neutral rating and EUR 52 price target. The analyst is encouraged by the company’s improving performance buy says this is largely understood in the current share price.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FMS: